Lakewood-Amedex Biotherapeutics Inc. Common Stock

NASDAQ: LABT · Healthcare · Biotechnology

PublicHQ University Park, FLCIK 0002079272Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 17

v0.1 · 5/100 weight · pillars only

↑ market scale, workforce scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$1.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Lakewood-Amedex Biotherapeutics Inc. Common Stock has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Restart Life Sciences Corp.——Neon Bloom, Inc.——Nu-Med Plus, Inc.23D Ovation Science Inc.23D

Key facts

CEOKelvin Cooper

SectorHealthcare

IndustryBiotechnology

HeadquartersUniversity Park, FL

ExchangeNASDAQ: LABT

Employees5

IPO date2026-04-23

Latest filings

8-K2026-06-17 10-Q2026-05-22 8-K2026-04-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.